Billing and Coding: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease

This billing and coding article provides claim reporting instructions for the Decipher Biopsy Prostate Cancer Classifier for men with favorable intermediate risk prostate cancer. Claims must include the appropriate CPT code, one unit of service, the correct ICD-10-CM diagnosis code, and the DEX Z-Code identifier adjacent to the CPT code in the specified Part A and Part B claim fields; see LCD DL38303 for detailed clinical coverage criteria and exclusions.

"Decipher Biopsy Prostate Cancer Classifier is intended for male patients with prostate cancer classified as favorable intermediate risk."

Sign up to see full coverage criteria, indications, and limitations.